2012
DOI: 10.1007/s11884-012-0139-6
|View full text |Cite
|
Sign up to set email alerts
|

Biologic Materials for Pelvic Floor Reconstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 87 publications
0
5
0
Order By: Relevance
“…Based on the Gomelsky et al paper, any graft significantly reduces objective prolapse recurrence rates compared to no graft. Gomelsky et al concluded that there is a lack of data supporting the use of biologics in pelvic prolapse repair and that more randomized controlled trials must be conducted to determine which graft is superior-synthetic vs. biologic [1].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on the Gomelsky et al paper, any graft significantly reduces objective prolapse recurrence rates compared to no graft. Gomelsky et al concluded that there is a lack of data supporting the use of biologics in pelvic prolapse repair and that more randomized controlled trials must be conducted to determine which graft is superior-synthetic vs. biologic [1].…”
Section: Discussionmentioning
confidence: 99%
“…The treatments for POP include the following: Pelvic floor therapy, pessaries, and surgical treatment. The estimated number of women that have a lifetime risk of undergoing an operation for a POP is 11% [1]. In April 2019, the FDA took surgical mesh for transvaginal use off the market due to safety and effectiveness concerns (mesh erosion).…”
Section: Introductionmentioning
confidence: 99%
“…Decellularized scaffolds from various organs and animals have shown signs of providing support through remodeling, while minimizing the inflammatory host response that leads to complications [1]. Previous limited clinical studies have not been able to show consistent advantages of xenograft use [6][7][8] but there is evidence of significant diversity among the different types of xenografts, precluding their treatment as a homogenous group [9].…”
Section: Introductionmentioning
confidence: 99%
“…15,16 Consequently, cross-linked matrices have been associated with comparable or increased complication rates relative to that for the polypropylene mesh in prolapse surgeries. 17,18 In this study, we used a 2-ply MatriStem in our composite graft to counteract the degenerative changes induced by Gynemesh PS (referred to as Gynemesh going forward) with minimal impact on its mechanical properties. To evaluate the potential of using MatriStem alone in prolapse repair, we chose a 6-layered product (MatriStem pelvic floor matrix) with mechanical properties in the range of those of polypropylene mesh 19 and slowed degradation rate for replacement by host tissue.…”
Section: Introductionmentioning
confidence: 99%